Tissue angiotensin II as a modulator of erectile function. I. Angiotensin peptide content, secretion and effects in the corpus cavernosum

Journal of Urology

Volumn 157, Issue 5, 1997, Pages 1920-1925

  Kifor, Imre ^a   Williams, Gordon H ^b   Vickers, Martyn A ^b   Sullivan, Maryrose P ^b   Jodbert, Patrice ^b   Dluhy, Robert G ^b  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b NONE

Author keywords

Ang II antagonists; angiotensin II; erectile function; losartan; tissue angiotensin

Indexed keywords

ANGIOTENSIN; CALCIUM ION; LOSARTAN; PAPAVERINE; PROSTAGLANDIN E1;

ANIMAL EXPERIMENT; ARTICLE; CALCIUM CELL LEVEL; CONTROLLED STUDY; CORPUS CAVERNOSUM; DOG; HUMAN; HUMAN TISSUE; MALE; NONHUMAN; PENIS ERECTION; PRIORITY JOURNAL; SMOOTH MUSCLE CONTRACTILITY;

EID: 0030893387     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5347(01)64901-2     Document Type: Article

References (45)

1. Lerner, S. A., Melman, A. and Christ, G. J.: A review of erectile dysfunction: New insights and more questions. J. Urol., 149: 1246, 1993.
2. Andersson, K. E. and Wagner, G.: Physiology of penile erection. Physiological Reviews, 75: 191, 1995.
3. Lue, T. F. and Tanagho, E. A: Physiology of erection and pharmacological management of impotence. J. Urol., 137: 829, 1987.
4. von Heyden, B., Donatucci, C. F., Kaula, N. and Lue, T. F.: Intra cavernous pharmacotherapy for impotence: Selection of appropriate agent and dose. J. Urol., 149: 1288, 1993.
5. Wespes, E. and Schulman, C.: Venous impotence: pathophysiology, diagnosis and treatment. J. Urol., 149: 1238, 1993.
6. Andersson, K. E.: Pharmacology of lower urinary tract smooth muscles and penile erectile tissues. Pharmacological Reviews, 45: 254, 1993.
7. Navar, L. G., Inscho, E. W., Majid, D. S. A., Imig, J. D., Harrison-Bernard, L. M. and Mitchell, K. D.: Paracrine regulation of the renal microcirculation. Physiological Reviews, 76: 425, 1996.
8. Sigmon, D. H. and Beierwaltes, W. H.: Renal nitric oxide and angiotensin II interaction in renovascular hypertension. Hypertension, 22: 237, 1993.
9. De Nicola, L., Blantz, R. C. and Gabbai, F. B.: Nitric oxide and angiotensin II. J. Clin. Invest., 89: 1248, 1992.
10. Kifor, I. and Dzau, V. J.: Endothelial renin-angiotensin pathway: evidence for intracellular synthesis and secretion of angiotensins. Circulation Research, 60: 422, 1987.
11. Sadoshima, J., Xu, Y., Slayter, H. S. and Izumo, S.: Autocrine release of angiotensin II mediates stretch-induced hypertrophy of cardiac myocytes in vitro. Cell, 75: 977, 1993.
12. Schmidt, H. H. H. W. and Walter, U.: NO at work. Cell, 78: 919, 1994.
13. Pollock, D. M., Polakowski, J. S., Divish, B. J. and Opgenorth, T. J.: Angiotensin blockade reverses hypertension during long-term nitric oxide synthase inbition. Hypertension, 21: 660, 1993.
14. Kumagai, H., Averill, D. B., Khosla, M. C. and Ferrairo, C. M.: Role of nitric oxide and angiotensin II in the regulation of sympathetic nerve activity in spontaneously hypertensive rats. Hypertension, 21: 476, 1993.
15. Sigmon, D. H., Carretero, O. A. and Beierwaltes, W. H.: Angiotensin dependence of endothelium-mediated renal hemodynamics. Hypertension, 20: 643, 1992.
16. Timmermans, P. B. M. W. M., Carini, D. J., Chiu, A. T., Duncia, J. V., Price, W. A., Wells, G. J., Wong, P. C., Wexler, R. R. and Johnson, A. L.: Angiotensin II receptor antagonists: from discovery to antihypertensive drugs. Hypertension, 18[suppl 5]: III-136, 1991.
17. Kifor, I., Moore, T. J., Fallo, F., Sperling, E., Menachery, A., Chiou, C-Y. and Williams, G. H.: The effect of sodium intake on angiotensin content of the rat adrenal gland. Endocrinology, 128: 1277, 1991.
18. Fisher, N. D. L., Allan, D., Kifor, I., Gaboury, C. L., Williams, G. H., Moore, T. J. and Hollenberg, N. K.: Responses to converting enzyme and renin inhibition: role of Angiotensin II in humans. Hypertension, 23: 44, 1994.
19. Kifor, I., Moore, T. J., Fallo, F., Sperling, E., Chiou, C-Y., Menachery, A. and Williams, G. H.: Potassium stimulated angiotensin release from superfused adrenal capsules and enzymatically dispersed cells of the zona glomerulosa. Endocrinology, 129: 823, 1991.
20. Dzau, V. J., Gibbons, G. H., Morishita, R. and Pratt, R. E.: New perspectives in hypertension research. Potentials of vascular biology. Hypertension, 23: 1132, 1994.
21. Inagami, T., Naruse, M. and Hoover, R.: Endothelium as an endocrine organ. Ann. Rev. Physiol., 57: 171, 1995.
22. Bokvist, K., Eliasson, L., Ammala, C., Renstrom, E. and Rorsman, P.: Co-localization of L-type Ca2+ channels and insulin-containing secretory granules and its significance for the initiation of exocytosis in mouse pancreatic B-cells. EMBO J., 14: 50, 1995.
23. Munzenmayer, D. H. and Greene, E. S.: Angiotensin II mediates a sustained rise in nuclear and cytoplasmic calcium via multiple receptor subtypes. Am. J. Physiol., 269: H565, 1995.
24. Orlov, S., Resnik, T. J., Bernhardt, J., Ferracin, F. and Buhler, F. R.: Vascular smooth muscle cell calcium fluxes. Regulation by Ang II and lipoproteins. Hypertension, 21: 195, 1993.
25. Klinge, E. and Sjostrand, N. O.: Comparative study of some isolated mammalian smooth muscle effectors of penile erection. Acta Physiol. Scand., 100: 354, 1977.
26. Emori, T., Hirata, Y., Ohta, K., Kanno, K., Eguchi, S., Imai, T., Shichiri, M. and Marumo, F.: Cellular mechanism of endothelin-1 release by angiotensin and vasopressin. Hypertension, 18: 165, 1991.
27. Bacic, F., Uematsu, S., McCarron, R. M. and Spatz, M.: Secretion of immunoreactive endothelin-1 by capillary and microvascular endothelium of human brain. Neurochem. Res., 17: 699, 1992.
28. Spatz, M., Stanimirovic, D., Bacic, F., Uematsu, S. and McCarron, R. M.: Vasoconstrictive peptides induce endothelin-1 and prostanoids in human cerebromicrovascular endothelium. Am. J. Physiol., 266: C654, 1994.
29. Steele, M. K. and Myers, L. S.: In vivo studies on paracrine actions of pituitary angiotensin II in stimulating prolactin release in rats. Am. J. Physiol., 258: E619, 1990.
30. Bredt, D. S. and Snyder, S. H.: Nitric oxide: a physiologic messenger molecule. Ann. Rev. Biochem., 63: 175, 1994.
31. Gross, S. S. and Wolin, M. S.: Nitric oxide: pathophysiological mechanisms. Ann. Rev. Physiol., 57: 737, 1995.
32. Zheng, X-F., Kwan, C-Y. and Daniel, E. E.: Role of intracellular calcium in EDRF release in rat aorta. J. Vasc. Res., 31: 18, 1994.
33. ++], in vascular smooth muscle by inhibition of the calcium current. Cell Calcium, 15: 122, 1994.
34. Derouet, H., Eckert, R., Trautwein, W. and Ziegler, M.: Muscular cavernous single cell analysis in patients with venoocclusive dysfunction. Eur. Urol., 25: 145, 1994.
35. 45Ca-uptake in isolated urinary bladder. Urol. Res., 19: 313, 1991.
36. Burgoyne, R. D. and Morgan, A.: Regulated exocytosis. Biochem. J., 293: 305, 1993.
37. Zerrouk, A., Auguet, M., Chabrier, P. E. and Braquet, P.: Endothelial inducible nitric oxide synthase mediates the contractile desensitization of angiotensin II in rat aorta. In: The Biology of Nitric Oxide. Physiological and Clinical Aspects. Edited by S. Moncada, M. Feelish, R. Busse, E. A. Higgins. London: Portland Press, pp. 108-110, 1994.
38. Phillips, M. L, Speakman, E. A. and Kimura, B.: Levels of angiotensin and molecular biology of the tissue renin angiotensin system. Regulatory Peptides, 43: 1, 1993.
39. Kato, H., Iwai, N., Inui, H., Kimoto, K., Uchiyama, Y. and Inagami, T.: Regulation of vascular angiotensin release. Hypertension, 21: 446, 1993.
40. Menachery, A., Braley, L. M., Kifor, I., Gleason, R. and Williams, G. H.: Dissociation in plasma renin and adrenal Ang II and aldosterone responses to sodium restriction in rats. Am. J. Physiol., 261: E487, 1991.
41. Chiou, C-Y., Williams, G. H. and Kifor, I.: Study of the rat adrenal renin-angiotensin system at a cellular level. J. Clin. Invest., 96: 1375, 1995.
42. Ryder, R. E., Close, R. F., Moriarty, K. T., Moore, K. T. and Hardisty, C. A.: Impotence in diabetes: aetiology, implications for treatment and preferred vacuum devices. Diabet. Med., 9: 893, 1992.
43. Pickard, R. S., Powell, P. H. and Zar, M. A.: Evidence against vasoactive intestinal peptide as the relaxant neurotransmitter in human cavernosal smooth muscle. Br. J. Pharmacol., 108: 497, 1993.
44. Feldman, H. A., Goldstein, I. and Hatzichristou, D. G.: Impotence and its medical and psychosocial correlates: results of the Massachusetts male aging study. J. Urol., 151: 54, 1994.
45. De Tejada, S., Goldstein, I. and Azadzoi, K.: Impaired neurogenic and endothelium mediated relaxation of penile smooth muscle from diabetic men with impotence. New Engl. J. Med., 320: 1025, 1989.